Combining GLP1s with Hormone Therapy for Greater Weight Loss Research indicates that combining GLP1 weight loss shots with hormone therapy may boost weight loss results by up to 30 percent compared to using GLP1 medications alone
To study how benefits are distributed, we stratify people by age at treatment initiation and by risk assessed one of two ways: BMI at time of treatment initiation
Discounted pricing and additional information available on the BioTe web store
The outcomes of these interventions have demonstrated inconsistency, with previous research predominantly focusing on mixed types of PUFAs (EPA combined with DHA) rather than examining EPA or DHA individually
Medical Impact In 2024, the NCD Risk Factor Collaboration (NCD-RisC) released data estimating that over one billion people worldwide are now living with obesity, including nearly 880 million adults and 159 million children and adolescents aged 519
For a deeper dive into this benefit area, you can also explore our Healthy-Aging collection
